Edwards Lifesciences (EW) PT Raised to $105 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $84.24 --0%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 20
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 20
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Edwards Lifesciences (NYSE: EW) to $105.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- First Majestic Silver (AG) PT Lowered to $25.50 at H.C. Wainwright
- Independence Group NL (IGO:AU) (IPGDF) PT Lowered to AUD8.10 at Goldman Sachs
- Zscaler (ZS) PT Raised to $265 at Citizens on Land Opportunity from Zero Trust Branch
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
